Robert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
India-Pakistan T20 Clash In New York Today: Here’s What To Know About The Biggest Cricket Game Of The Year
Trump Hush Money Judge Says Juror’s Supposed ‘Cousin’ Predicted A Conviction On Facebook—But It’s Unclear If It’s TrueA panel of experts advising the Food and Drug Administration could on Monday recommend Eli Lilly’s experimental Alzheimer’s drug donanemab for FDA approval, a closely watched decision that could pave the way for the drug to become the second of its kind authorized in the U.S..
Data and concerns surrounding donanemab are roughly in line with those for Leqembi, the brand name for Biogen and Eisai’s Alzheimer’s treatment lecanemab, which became the first fully authorized treatment for Alzheimer’s in the U.S. last year. Both drugs — antibodies that combat the buildup of amyloid proteins in the brain that experts believe play a key role in Alzheimer’s disease — have been hailed as the heralds of a new era in Alzheimer's medicine after years of failing to develop treatments to meaningfully stop or reverse the terminal decline.The FDA is not required to follow the recommendations of its expert panels but it does put significant weight in their opinions.
Eli Lilly Dementia Drug Donanemab Biogen Leqembi FDA Side Effects Brain Bleeding
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Biden Wants To Take Your CarSteve Forbes is Chairman and Editor-in-Chief of Forbes Media.
Read more »
Buffett's 2024 Investment Wisdom: Psychology Matters As Much As FinancialsI am the editor of three Forbes investment newsletters: Forbes Dividend Investor, Forbes Billionaire Investor and covered call writing advisory service, Forbes Premium Income Report. Prior to joining Forbes in 2001, I was a producer and reporter at CNN Financial News, focusing on stories about entrepreneurship.
Read more »
Alphabet taps Eli Lilly's Anat Ashkenazi as new CFOThe new Google executive will replace Ruth Porat, who will become president and chief investment officer of the company after nearly a decade as CFO.
Read more »
Paul Giamatti Checks Into New ‘Hostel’ TV Series From Eli RothPaul Giamatti on the BAFTA red carpet
Read more »
Eli Roth's Hostel Becoming TV Series Starring Paul GiamattiChris Briggs and Mike Fleiss will executive produce.
Read more »
Texans star CJ Stroud wants Eli Manning's career over Aaron Rodgers': 'You want the rings'If C.J. Stroud had the choice of Eli Manning's career or Aaron Rodgers', he said he'd choose the New York Giants legend's due to the number of Super Bowl rings he has.
Read more »